Dolat Capital Market has given Buy recommendation for JB Chemicals and Pharmaceuticals with a target price of Rs. 1356 in its research report issued on Mar 02, 2021
Dolat Capital Market’s research report on JB Chemicals and Pharmaceuticals
JBCPL hosted virtual analyst meet to share its mid to long term vision post the change in management after the buyout by PE firm KKR (54%) in July’20. The new management laid out a 6-point framework for sustainable mid-teens growth via therapy diversification, productivity improvement, leveraging existing capabilities in CMO, exploring M&A (brands, portfolio) and focus on deepening existing base through digitization.
Outlook
At CMP, stock trades at 24.7x FY22E and 21x FY23E EPS of Rs48.8 and Rs56.7 respectively